Safilo Group Reports Preliminary Full Year 2022 Performance Indicators

By Staff
Monday, January 30, 2023 12:18 AM PADUA, Italy—The Board of Directors of Safilo Group S.p.A. has reviewed the Group’s preliminary key performance indicators for the financial year ended Dec. 31, 2022 and the full year annual results will be approved by the Board of Directors on March 9, 2023.

Johnson & Johnson Reports Q4 Sales Decline But Shows Growth Over 2022 Full Year

By Staff
Wednesday, January 25, 2023 12:21 AM NEW BRUNSWICK, N.J.—Johnson & Johnson (NYSE: JNJ) reported Tuesday that its total group sales for the fourth quarter of 2022 declined 4.4 percent with full-year sales growth of 1.3 percent.

Harrow Closes Acquisition of U.S. Rights to Five Ophthalmic Products

By Staff
Tuesday, January 24, 2023 12:18 AM NASHVILLE, Tenn.—Harrow (Nasdaq: HROW), an ophthalmic-focused health care company, announced the closing of its previously announced acquisition of the exclusive U.S. commercial rights to five branded ophthalmic products: Ilevro, Nevanac, Vigamox, Maxidex and Triesence.

Nicox Reports Fourth Quarter 2022 and Full-Year Financial Results

By Staff
Friday, January 20, 2023 12:27 AM SOPHIA ANTIPOLIS, France—Nicox SA (Euronext Paris: FR0013018124, COX), an international ophthalmology company, reported net revenue of  €1.0 million for fourth quarter 2022, ended Dec. 31, 2022, versus net revenue for the fourth quarter of 2021 of €3.5 million. Net revenue for full year 2022 was €3.3 million compared to net revenue for 2021 of €7.2 million. As of Dec. 31, 2022, the Nicox Group had cash and cash equivalents of €27.7 million compared with €42.0 million as of December 31, 2021 and €25.6 million as of September 30, 2022.

Bausch + Lomb Enhances Surgical Portfolio With Acquisition of AcuFocus, Inc.

By Staff
Thursday, January 19, 2023 12:27 AM VAUGHAN, Ontario—Bausch + Lomb Corporation, a leading global eye health company, and AcuFocus, Inc., a privately held ophthalmic medical device company, announced that an affiliate of Bausch + Lomb has acquired AcuFocus, pursuant to a merger transaction with the parent company of AcuFocus.

IDOC and Three Rivers Optical Combine to Form Company Dedicated to Serving Independent Eyecare Practices

By Staff
Tuesday, January 17, 2023 11:45 AM NORWALK, Conn.—Two renowned industry leaders, IDOC, the largest independent optometric alliance, and Three Rivers Optical, a leading independent optical laboratory, have combined “to bring an unmatched suite of practice enhancement and lab services to eyecare professionals,” the announcement said. The two companies, with a 75-plus year combined history of serving optometry, have a shared mission of continuing the growth and success of independent eyecare practices. Both IDOC and Three Rivers Optical will continue operating in the marketplace under their existing names.

STAAR Surgical Reports Preliminary Net Sales for 4Q and Fiscal 2022

By Staff
Tuesday, January 10, 2023 12:18 AM LAKE FOREST, Calif.—STAAR Surgical Company (NASDAQ: STAA), a developer, manufacturer and marketer of implantable lenses for the eye, reported preliminary net sales were approximately $64 million for the fourth quarter and approximately $284 million for fiscal 2022.

AOA Accepting Nominations for Paraoptometric and Hall of Fame Awards

By Staff
Tuesday, January 10, 2023 12:15 AM ST. LOUIS—The American Optometric Association (AOA) is accepting nominations for the 2023 AOA Paraoptometric of the Year, Paraoptometric Community Service, and Paraoptometric Lifetime Achievement awards.

U.S. Optical Retail Market Estimated at $76.5 Billion in The Vision Council’s First Comprehensive Market inSights Report

By Staff
Friday, January 6, 2023 12:27 AM ALEXANDRIA, Va.—Today, The Vision Council will release its first set of comprehensive industry estimates since last year’s inSights Research Program launch. The inaugural Market inSights 2022 Report estimates that the overall size of the U.S. optical retail industry was $76.5 billion as compared to $76.09 billion for 2021, according to an announcement from The Vision Council. Both the 2021 and 2022 figures use the new methodology associated with The Vision Council's Market inSights Report.

Viatris Closes Acquisitions of Oyster Point Pharma and Famy Life Sciences, Establishes New Eyecare Division

By Staff
Friday, January 6, 2023 12:15 AM PITTSBURGH—Viatris Inc., a global health care company, has closed its acquisitions of Oyster Point Pharma and Famy Life Sciences to establish a new Viatris Eyecare Division. The transaction was first reported in VMAIL as part of Viatris' strategic update.

1847 Holdings to Acquire ICU Eyewear

By Staff
Friday, December 23, 2022 12:24 AM NEW YORK—1847 Holdings announced that its wholly owned subsidiary has signed a definitive agreement to acquire ICU Eyewear Holdings Inc., a leading designer of over-the-counter (OTC), non-prescription reading glasses, sunglasses, blue light blocking eyewear, sun readers and outdoor specialty sunglasses.

Cleinman Performance Partners Welcomes Allied Financial Partners

By Staff
Friday, December 23, 2022 12:18 AM ONEONTA, N.Y.—Cleinman Performance Partners, based here, announced it has formed a collaborative relationship with Allied Financial Partners, a New York-based full-service financial management firm. The alliance will deliver a new resource for Cleinman’s partner optometry practices throughout North America. “I consider good financial management to be the heart of any good business, without which good decisions are challenging," said Alan Cleinman, CEO and founder. "We are delighted to provide our partner practices with the outstanding resources of Allied Financial Partners. Our respective firms are committed to delivering the very best financial management to our clients.”

Zeiss Group Reports Significant Revenue Growth in Fiscal Year 2021/22

By Staff
Thursday, December 15, 2022 12:27 AM OBERKOCHEN, Germany—The Zeiss Group reported significant revenue growth for the fiscal year ended Sept. 30, 2022, with all four of the company’s business segments generating double-digit percentage growth.

By Selling its Eyewear Division to De Rigo, Rodenstock Will Focus on Med-Tech

By Staff
Wednesday, December 14, 2022 12:24 AM MUNICH—De Rigo Vision’s recent announcement that it is acquiring the eyewear division of The Rodenstock Group clears the way for Rodenstock to focus exclusively on its well-established spectacle lens business and further develop its medical and vision technology capabilities.

Carl Zeiss Meditec Stays on Growth Track in Fiscal Year 2021/22

By Staff
Monday, December 12, 2022 12:24 AM JENA, Germany—Carl Zeiss Meditec reported revenue of around €1,903 million in fiscal year 2021/22 versus €1,647 million in the prior year, a 15.5 percent increase (up 13.3 percent, adjusted for currency effects). Orders received increased even more significantly to around €2,251 million, up 30.1 percent (up 27.7 percent, adjusted for currency effects), according to Meditec, based here. Earnings before interest and taxes (EBIT) increased to around €397 million, versus €374 million in the prior year. The EBIT margin was 20.9 percent compared with 22.7 prior year.